Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Genomic Profiling of Cancers of Unknown Primary Site—Reply

Genomic Profiling of Cancers of Unknown Primary Site—Reply Letters Corresponding Author: Young E. Whang, MD, PhD, Lineberger Comprehensive COMMENT & RESPONSE Cancer Center, University of North Carolina School of Medicine, 450 West Dr, Genomic Profiling of Cancers of Unknown Chapel Hill, NC 27599-7295 (ywhang@med.unc.edu). Primary Site: The Next Steps Published Online: May 14, 2015. doi:10.1001/jamaoncol.2015.0936. To the Editor A recent article by Ross et al reported the results Conflict of Interest Disclosures: None reported. of comprehensive genomic profiling of cancers of unknown pri- 1. Ross JS, Wang K, Gay L, et al. Comprehensive genomic profiling of carcinoma mary (CUPs) and documents frequent occurrence of clini- of unknown primary site: new routes to targeted therapies [published online February 12, 2015]. JAMA Oncol. doi:10.1001/jamaoncol.2014.216. cally relevant genomic alterations. We describe herein the out- 2. Kodaira M, Takahashi S, Yamada S, et al. Bone metastasis and poor come of a case of CUP, which may serve to illustrate both the performance status are prognostic factors for survival of carcinoma of unknown benefit of personalized therapy and potential pitfalls. primary site in patients treated with systematic chemotherapy. Ann Oncol. A man in his 60s presented with CUP involving bones 2010;21(6):1163-1167. and lymph nodes. He had a history of stage II testicular http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Genomic Profiling of Cancers of Unknown Primary Site—Reply

Download PDF
3 pages

Loading next page...
 
/lp/american-medical-association/genomic-profiling-of-cancers-of-unknown-primary-site-reply-vbKmIPDRpQ

References (11)

Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2015.0945
pmid
26181269
Publisher site
See Article on Publisher Site

Abstract

Letters Corresponding Author: Young E. Whang, MD, PhD, Lineberger Comprehensive COMMENT & RESPONSE Cancer Center, University of North Carolina School of Medicine, 450 West Dr, Genomic Profiling of Cancers of Unknown Chapel Hill, NC 27599-7295 (ywhang@med.unc.edu). Primary Site: The Next Steps Published Online: May 14, 2015. doi:10.1001/jamaoncol.2015.0936. To the Editor A recent article by Ross et al reported the results Conflict of Interest Disclosures: None reported. of comprehensive genomic profiling of cancers of unknown pri- 1. Ross JS, Wang K, Gay L, et al. Comprehensive genomic profiling of carcinoma mary (CUPs) and documents frequent occurrence of clini- of unknown primary site: new routes to targeted therapies [published online February 12, 2015]. JAMA Oncol. doi:10.1001/jamaoncol.2014.216. cally relevant genomic alterations. We describe herein the out- 2. Kodaira M, Takahashi S, Yamada S, et al. Bone metastasis and poor come of a case of CUP, which may serve to illustrate both the performance status are prognostic factors for survival of carcinoma of unknown benefit of personalized therapy and potential pitfalls. primary site in patients treated with systematic chemotherapy. Ann Oncol. A man in his 60s presented with CUP involving bones 2010;21(6):1163-1167. and lymph nodes. He had a history of stage II testicular

Journal

JAMA Oncology – American Medical Association

Published: Jul 1, 2015

There are no references for this article.